It's not often that marijuana legalization supporters and opponents agree on the negative implications of cannabis's classification under federal law. That's something activists working to end the criminalization of marijuana and otherwise change its legal status have been saying for decades. Meanwhile, many of the same legalization opponents who make up the group behind the new congressional submission pointing out research roadblocks have repeatedly argued that federal law doesn't stand in the way of cannabis studies. Schedule I is supposed to be reserved for drugs with a high potential for abuse and no medical value. Researchers and advocates have often said that studies on substances classified there have to overcome approval hurdles that don't exist for other substances.

Source: Forbes May 03, 2018 20:15 UTC